Literature DB >> 24499428

Caffeine-based gold(I) N-heterocyclic carbenes as possible anticancer agents: synthesis and biological properties.

Benoît Bertrand1, Loic Stefan, Marc Pirrotta, David Monchaud, Ewen Bodio, Philippe Richard, Pierre Le Gendre, Elena Warmerdam, Marina H de Jager, Geny M M Groothuis, Michel Picquet, Angela Casini.   

Abstract

A new series of gold(I) N-heterocyclic carbene (NHC) complexes based on xanthine ligands have been synthesized and characterized by mass spectrometry, NMR, and X-ray diffraction. The compounds have been tested for their antiproliferative properties in human cancer cells and nontumorigenic cells in vitro, as well as for their toxicity in healthy tissues ex vivo. The bis-carbene complex [Au(caffein-2-ylidene)2][BF4] (complex 4) appeared to be selective for human ovarian cancer cell lines and poorly toxic in healthy organs. To gain preliminary insights into their actual mechanism of action, two biologically relevant in cellulo targets were studied, namely, DNA (more precisely a higher-order DNA structure termed G-quadruplex DNA that plays key roles in oncogenetic regulation) and a pivotal enzyme of the DNA damage response (DDR) machinery (poly-(adenosine diphosphate (ADP)-ribose) polymerase 1 (PARP-1), strongly involved in the cancer resistance mechanism). Our results indicate that complex 4 acts as an efficient and selective G-quadruplex ligand while being a modest PARP-1 inhibitor (i.e., poor DDR impairing agent) and thus provide preliminary insights into the molecular mechanism that underlies its antiproliferative behavior.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24499428     DOI: 10.1021/ic403011h

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  21 in total

1.  Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipy(c.).

Authors:  Luigi Messori; Maria Agostina Cinellu; Antonello Merlino
Journal:  ACS Med Chem Lett       Date:  2014-07-31       Impact factor: 4.345

2.  Ex vivo toxicological evaluation of experimental anticancer gold(i) complexes with lansoprazole-type ligands.

Authors:  Natalia Estrada-Ortiz; Elena Lopez-Gonzales; Ben Woods; Stefan Stürup; Inge A M de Graaf; Geny M M Groothuis; Angela Casini
Journal:  Toxicol Res (Camb)       Date:  2019-09-20       Impact factor: 3.524

3.  Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents.

Authors:  Benoît Bertrand; Anna Citta; Inge L Franken; Michel Picquet; Alessandra Folda; Valeria Scalcon; Maria Pia Rigobello; Pierre Le Gendre; Angela Casini; Ewen Bodio
Journal:  J Biol Inorg Chem       Date:  2015-07-23       Impact factor: 3.358

4.  N-Heterocyclic Carbene Complexes of Nickel(II) from Caffeine and Theophylline: Sustainable Alternative to Imidazol-2-ylidenes.

Authors:  Jin Zhang; Mahbubur Rahman; Qun Zhao; Jessica Feliciano; Elwira Bisz; Błażej Dziuk; Roger Lalancette; Roman Szostak; Michal Szostak
Journal:  Organometallics       Date:  2022-04-05       Impact factor: 3.837

5.  Noble Metal Complexes of a Bis-Caffeine Containing NHC Ligand.

Authors:  Oliver Bysewski; Andreas Winter; Phil Liebing; Ulrich S Schubert
Journal:  Molecules       Date:  2022-07-05       Impact factor: 4.927

6.  Biscarbene gold(i) complexes: structure-activity-relationships regarding antibacterial effects, cytotoxicity, TrxR inhibition and cellular bioavailability.

Authors:  Claudia Schmidt; Bianka Karge; Rainer Misgeld; Aram Prokop; Mark Brönstrup; Ingo Ott
Journal:  Medchemcomm       Date:  2017-06-27       Impact factor: 3.597

7.  N-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug Delivery.

Authors:  Weijia Niu; Xigao Chen; Weihong Tan; Adam S Veige
Journal:  Angew Chem Int Ed Engl       Date:  2016-06-17       Impact factor: 15.336

8.  Targeting Telomeres: Molecular Dynamics and Free Energy Simulation of Gold-Carbene Binding to DNA.

Authors:  Asmar Nayis; Korbinian Liebl; Christina V Frost; Martin Zacharias
Journal:  Biophys J       Date:  2020-12-05       Impact factor: 4.033

9.  The coffee genome hub: a resource for coffee genomes.

Authors:  Alexis Dereeper; Stéphanie Bocs; Mathieu Rouard; Valentin Guignon; Sébastien Ravel; Christine Tranchant-Dubreuil; Valérie Poncet; Olivier Garsmeur; Philippe Lashermes; Gaëtan Droc
Journal:  Nucleic Acids Res       Date:  2014-11-11       Impact factor: 16.971

10.  Targeting Antioxidant Pathways with Ferrocenylated N-Heterocyclic Carbene Supported Gold(I) Complexes in A549 Lung Cancer Cells.

Authors:  J F Arambula; R McCall; K J Sidoran; D Magda; N A Mitchell; C W Bielawski; V M Lynch; J L Sessler; K Arumugam
Journal:  Chem Sci       Date:  2015-10-29       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.